Australian REITS Stock News

ASX:RAC
ASX:RACBiotechs

Are Race Oncology's (ASX:RAC) New Bisantrene Patents a Turning Point for Its Competitive Edge?

Earlier this week, Race Oncology announced a scientific discovery regarding the composition of the chemotherapy drug Bisantrene and has filed three patent applications based on these findings. This move highlights the company’s continued research efforts to strengthen its intellectual property protection in the oncology treatment space. We’ll explore how Race Oncology’s patent applications on new Bisantrene discoveries may influence its investment narrative and future opportunities. Find...
ASX:CYC
ASX:CYCMedical Equipment

ASX Penny Stocks Spotlight: Alcidion Group And 2 Other Noteworthy Picks

As the Australian market follows the global uptick, with ASX 200 futures indicating a positive start, investors are keenly observing opportunities that arise from this buoyant sentiment. Penny stocks, though an older term, still capture interest due to their potential for growth and value in smaller or newer companies. In this context, we explore three noteworthy penny stocks on the ASX that stand out for their financial robustness and potential to offer significant returns over time.